Overview
Adhesives maker's Q1 net revenue fell 2% yr/yr, missing analyst expectations
Adjusted EPS for Q1 rose 6% yr/yr, beating analyst expectations
Outlook
H.B. Fuller raises full-year net revenue guidance to up mid-single digits
Company expects fiscal 2026 adjusted EBITDA of $645 mln to $675 mln
H.B. Fuller sees fiscal 2026 adjusted EPS of $4.55 to $4.90
Result Drivers
LOWER VOLUMES - Organic revenue fell 6.6% yr/yrs
MARGIN EXPANSION - Adjusted gross margin rose 170 bps yr/yr, driven by restructuring savings from Quantum Leap, acquisitions, and targeted price and raw material cost actions
Company press release: ID:nBw3XNr7Pa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Net Revenue | Miss | $771 mln | $781.51 mln (7 Analysts) |
Q1 Adjusted EPS | Beat | $0.57 | $0.56 (7 Analysts) |
Q1 Adjusted Net Income | Beat | $32 mln | $30.51 mln (6 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for H.B. Fuller Company is $71.50, about 34.3% above its March 24 closing price of $53.23
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 13 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.